Drugs / Otovowen®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02345447 | Oct 2013 → Oct 2015 | otitis media | University Hospital Tuebingen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Otovowen | “This is a prospective, controlled parallel-group comparison for superiority of Otovowen®.” NCT02345447 ↗ |
| Route | Oral | “Mode of Application: orally” NCT02345447 ↗ |